Sleep Wake Advisor

06/07/2025

is reduced among those with and idiopathic hypersomnia with the greatest reductions occurring in narcolepsy type 2 and IH. From Neurology Advisor.

In a cross-sectional study, researchers assessed health-related quality of life (HRQoL) in patients with narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia, and what factors are tied HRQoL in these conditions.

05/07/2025

Delayed REML is associated with pathophysiologic changes in patients with AD and cognitive impairment. Published by Alzheimer's Association and Neurology Advisor.

In a cross-sectional study, researchers assessed the effect of rapid eye movement (REM) sleep features on Alzheimer disease (AD) biomarkers in older adults.

04/07/2025

Successfully treating with ocular lubricants significantly reduces severity. Published in Optometry Advisor.

Researchers investigated the efficacy of 2 different ocular lubricants on dry eye disease, migraine severity, and ocular symptoms.

03/07/2025

Individuals with are significantly more likely to develop , particularly insomnia, compared against those without RA. Published in Rheumatology Advisor.

Researchers evaluated whether rheumatoid arthritis is associated with an increased risk for sleep disorders and how this correlates with dementia risk.

02/07/2025

Personal and social factors were associated with reduced symptomology among young adults, though this may reflect research bias. Published in The Lancet Psychiatry.

Researchers conducted a systematic review analyzing examining how certain factors, such as social and environmental systems, influence emerging adult depression.

01/07/2025

In critically ill patients with obstructive , 365-day and 30-day all-cause mortality can be predicted by a novel marker — RSR — which is the ratio of RDW to SpO₂.

Researchers assessed how well RSR, a novel marker combining RDW and SpO₂, could predict mortality and assess prognosis in critically ill patients with OSA.

01/07/2025

In patients genetically predisposed to , risk increases for blepharochalasis, corneal ulcer, keratitis, and lacrimal system disorders, but decreases for glaucoma. From Ophthalmology Advisor.

Investigators evaluated a potential genetic links between patients at risk for attention-deficit/hyperactivity disorder and 13 ocular diseases.

29/06/2025

The regular use of , particularly strong opioids, is associated with an increased risk for among patients with chronic noncancer pain. Published in
Alzheimer's Association and Clinical Pain Advisor.

https://bit.ly/4lhBSpI

28/06/2025

Sleep characteristics are significantly associated with certain genetic markers. Published in Neurology Advisor.

In a retrospective study, researchers assessed the relationship between genetics of narcolepsy and sleep.

27/06/2025

Compared to lithium, quetiapine was more clinically and cost-effective for long-term augmentation in treatment-resistant , with greater symptom improvement, lower health-care costs, and similar safety and discontinuation rates over 12 months. Published in The Lancet and Psychiatry Advisor.

Researchers conducted a randomized controlled trial comparing the clinical and cost-effectiveness of lithium vs quetiapine augmentation therapy for patients with treatment-resistant depression over 12 months.

26/06/2025

Death anxiety is associated with and poor sleep quality, according to results of a systematic review and meta-analysis from Psychiatry Advisor.

https://bit.ly/4llinMP

26/06/2025

A link exists between stressor-evoked brain activity and preclinical , explained by stress-related blood pressure. Published in the journal of American Heart Association and The Cardiology Advisor.

https://bit.ly/44daqSZ